UK approves 'landmark' breast cancer drug
A new drug that helps slow the spread of an incurable type of breast cancer has been approved for use in Britain's state-run National Health Service, officials said on Friday.
Apr 11, 2025
0
23
MeSH tree: D08.811.913.696.620.682.700
A new drug that helps slow the spread of an incurable type of breast cancer has been approved for use in Britain's state-run National Health Service, officials said on Friday.
Apr 11, 2025
0
23
Our biceps and our brain cells may have more in common than previously thought.
Feb 8, 2025
1
59
A compound with the unpresuming designation of EBC-46 has made a splash in recent years for its cancer-fighting prowess. Now a new study led by Stanford researchers has revealed that EBC-46 also shows immense potential for ...
Jan 27, 2025
0
96
A decade ago, researchers introduced a new model for studying Alzheimer's disease. Known as "Alzheimer's in a dish," the model uses cultures of mature brain cells suspended in a gel to recapitulate what takes place in the ...
Nov 27, 2024
0
38
Professor Hiroki R. Ueda , Dr. Kazuhiro Kon and their colleagues at Graduate School of Medicine, The University of Tokyo, have published a study in Nature Communications on the importance of proper regulation of the activity ...
Aug 13, 2024
0
44
A new study in the Journal of Neuroscience has discovered underlying sex differences in the molecular pathways that drive reward-related behaviors. In particular, the study found differences and similarities in the ways males ...
Jun 27, 2024
0
485
The ketogenic diet has its fanatics and detractors among dieters, but either way, the diet has a scientifically documented impact on memory in mice. While uncovering how the high fat, low carbohydrate diet boosts memory in ...
Jun 18, 2024
0
319
Researchers at UNC Lineberger Comprehensive Cancer Center and colleagues have established the most comprehensive molecular portrait of the workings of KRAS, a key cancer-causing gene or "oncogene," and how its activities ...
Jun 6, 2024
0
45
Scientists have used breast cancer cells' weakness against themselves by linking a tumor-selective antibody with a cell-killing drug to destroy hard-to-treat tumors.
May 22, 2024
0
52
Glioblastoma is an often fatal form of brain cancer, with only 5% of patients surviving beyond five years. The cancer is difficult to treat and almost always becomes resistant to treatment. As a result, recurrence of glioblastoma ...
May 6, 2024
0
43